Seer to Present at the Cowen 43rd Annual Health Care Conference
February 21 2023 - 4:30PM
Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced that the
company will be participating in the upcoming Cowen 43rd Annual
Health Care Conference in Boston, MA.
Seer’s management is scheduled to participate in
a fireside chat and Q&A session on Wednesday, March 8th at 9:50
a.m. Eastern Time / 6:50 a.m. Pacific Time. A live webcast of the
session will be available on the Investor section of Seer’s website
at investor.seer.bio. An archived replay will be available on the
company’s website following the conference.
About Seer Seer™ is a life sciences company
developing transformative products that open a new gateway to the
proteome. Seer’s Proteograph™ Product Suite is an integrated
solution that includes proprietary engineered nanoparticles,
consumables, automation instrumentation and software to perform
deep, unbiased proteomic analysis at scale in a matter of hours.
Seer designed the Proteograph workflow to be efficient and easy to
use, leveraging widely adopted laboratory instrumentation to
provide a decentralized solution that can be incorporated by nearly
any lab. Seer’s Proteograph Product Suite is for research use only
and is not intended for diagnostic procedures. For more
information, please visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren Possematopr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jun 2024 to Jul 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jul 2023 to Jul 2024